Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Practices: Balazs Halmos, MD | AJMC
Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Pr…
6 months ago
ajmc.com
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC Management | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCL…
1 month ago
onclive.com
Implications of the FDA Approval of Subcutaneous Amivantamab in EGFR-Mutated NSCLC | OncLive
Implications of the FDA Approval of Subcutaneous Amivantamab in E…
3 weeks ago
onclive.com
Promising Efficacy Seen With Amivantamab Regimen in R/R Metastatic CRC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Promising Efficacy Seen With Amivantamab Regimen in R/R Met…
2 months ago
targetedonc.com
FDA Approval of Subcutaneous Amivantamab Is Significant Step Forward in NSCLC: Martin Dietrich, MD, PhD | AJMC
FDA Approval of Subcutaneous Amivantamab Is Significant Step F…
4 months ago
ajmc.com
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Targeted therapy in a shot: New approval for EGFR-mutated lung c…
3 months ago
MSNDr. Kaique Filardi
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory EGFR-Mutated, Advanced Non-Small Cell Lung Cancer (NSCLC): Primary Results, Including Overall Survival (OS), From the Global, Phase 3, Randomized Controlled PALOMA-3 Trial | OncLive
8:58
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both i…
Jun 25, 2024
onclive.com
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
Mitigating Potential IRRs with Amivantamab: Clinical Insights fro…
9 months ago
onclive.com
ESMO 2025 Insights: Amivantamab in Recurrent/Metastatic HNSCC Af…
5 months ago
vumedi.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsNov 21, 2021
vumedi.com
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…
Mar 4, 2024
ajmc.com
3:38
Updates from PAPILLON: 1L Amivantamab Chemotherapy in A…
Nov 14, 2023
targetedonc.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Adverse Event Management Strategies for Amivantamab-Base…
Feb 19, 2025
onclive.com
Dr Pietrantonio on Future Directions of Evaluating Amivantamab in CR…
Apr 4, 2025
onclive.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
Nov 30, 2023
onclive.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
Oct 21, 2023
onclive.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
Dr Arnold on the Evaluation of Chemo With Amivantamab or Cetu…
10 months ago
onclive.com
0:07
📣 The U.S. Food and Drug Administration has approved a ne…
259 views4 months ago
FacebookGO2 for Lung Cancer
5:12
Subcutaneous Amivantamab Reshapes Frontline EGFR-Mutant …
589 views1 month ago
YouTubeOncUpdates: Latest Oncology Insights
9:07
OS Benefit and Patient-Centered Delivery Advanced in EGFR-Positi…
603 views1 month ago
YouTubeOncUpdates: Latest Oncology Insights
1:13
Dr Mehra on the FDA Breakthrough Therapy Designation for Amivanta…
30 views2 weeks ago
YouTubeOncLive
3:01
About Advanced (Metastatic) Prostate Cancer
72.4K viewsNov 9, 2020
YouTubeMacmillan Cancer Support
4:06
How and Why Prostate Cancer Treatment Affects Men’s Lives
6K viewsJan 24, 2019
YouTubeMayo Clinic
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab f…
5K viewsJun 20, 2017
YouTubeTargeted Oncology
7:59
Radiation therapy for prostate can…
HIGHLY RANKED HOSPITAL
About this channel
YouTubeSunnybrook Hospital
See more videos
Static thumbnail place holder